English | Dutch |
acute lymphoblastic L3 leukemia | acute lymfoblastaire leukemie L3 |
1,3-bisphosphoglycerate | 1,3-bifosfoglyceraat |
ca-15-3 antigen | CA 15-3 |
3, 5-dinitro-2-toluamide | dinitolmide |
3, 5-dinitro-2-toluamide | E752 |
3, 5-dinitro-2-toluamide | 3,5-dinitro-2-toluamide |
2,3-diphosphoglycerate | 2,3-bifosfoglyceraat |
2,3-diphosphoglycerate | 2,3-difosfoglyceraat |
1,3-diphosphoglycerate | 1,3-bifosfoglyceraat |
glyceraldehyde 3-phosphate | glyceraldehyde-3-fosfaat |
glyceraldehyde-3-phosphate dehydrogenase | glyceraldehyde-3'-monofosfaat dehydrogenase |
'Group 3'biological agent | biologisch agens uit groep 3 |
human T-cell lymphotropic virus type 3 | Humaan T-lymfotroop virus type III |
LeFort type 3 fracture | fractuur Le Fort III |
Leu 3 | monoklonale OKT4-antilichamen |
Leu 3 | monoklonale Leu3-antilichamen |
marker hom 3-10 | hom 3-10 kenmerk |
3-phosphoglycerate | 3-fosfoglyceraat |
provitamin D3 | provitamine D3 |
SQ3R method | SQLRT-methode |
2, 3, 7, 8-tetrachlorodibenzo-para-dioxin | 2,3,7,8-tetrachloordibenzo-p-dioxine |
2, 3, 7, 8-tetrachlorodibenzo-p-dioxin | 2,3,7,8-tetrachloordibenzo-p-dioxine |
3, 5, 3', 5'-tetraiodothyronine | thyroxine |